Diagnostics News and Research

RSS

Study shows how cancer cells gain access to nerve signal to enter the bloodstream

Tumors come in many shapes and forms--curable or deadly, solid or liquid, lodged inside the brain, bone, or other tissues. One thing they all have in common, however, is a knack for molecular deceit.

1 Oct 2020

New commitments from governments and organizations support a unified approach to end pandemic

New commitments from governments, international organizations and the private sector support unified approach to end pandemic, backing a response of unprecedented scale, scope and speed - through the Access to COVID-19 Tools Accelerator - as pandemic claims more than 1 million lives

1 Oct 2020

NIH awards $5 million grant to reduce COVID-19-related health disparities

To help reduce COVID-19-related health disparities in vulnerable populations in Texas, a multi-institutional team of researchers led by The University of Texas Health Science Center at Houston will identify disease hotspots and testing deserts in three racially diverse areas, and then develop and evaluate intervention strategies to increase COVID-19 testing.

30 Sep 2020

Discovery of high affinity binders for SARS-CoV-2 spike protein

An exciting, 'tour-de-force' paper by researchers from the Massachusetts Institute of Technology describes de novo discovery of high-affinity peptide binders for SARS-CoV-2 spike glycoprotein, which opens the door for the development of rapid viral identification or conjugates for virus-directed delivery of therapeutics.

30 Sep 2020

Abacus Diagnostica's new multiplex assay provides reliable influenza, COVID-19 diagnosis in 75 minutes

Abacus Diagnostica is a small Finnish company developing and manufacturing assays and devices for rapid molecular diagnostics. Since the beginning of COVID-19 outbreak the company has worked decisively on the development of SARS-CoV-2 diagnostics.

30 Sep 2020

PrimeStore® MTM novel viral transport media successfully evaluated by Public Health England for SARS-CoV-2 inactivation

EKF Diagnostics announces that the novel viral transport media PrimeStore® MTM has been successfully evaluated for effective SARS-CoV-2 inactivation.

From EKF Diagnostics 29 Sep 2020

UCLA researchers receive $13 million NIH grant to combat melanoma

UCLA researchers have received a $13 million grant from the National Institutes of Health to find new ways to overcome melanoma resistance to some of the most promising targeted therapies and immunotherapies.

28 Sep 2020

New agreements to ensure all countries have fair access to COVID-19 rapid diagnostic tests

A set of agreements to make available, for low and middle-income countries, affordable, high-quality COVID-19 antigen rapid tests were today announced by the Access to COVID-19 Tools (ACT) Accelerator.

28 Sep 2020

Interdisciplinary team wins NIH grant to develop a device for early oral cancer detection

Mouth lesions are among the main early indicators of oral cancer, but determining whether a sore is actually malignant typically involves painful, costly biopsies.

28 Sep 2020

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

As COVID-19 quickly spread worldwide this spring, shortages of supplies, including the nasopharyngeal (nasal) swabs used to collect viral samples, limited diagnostic testing.

25 Sep 2020

New diagnostic tool may allow on-the-spot detection of coronavirus infection

Scientists at the University of Warwick have demonstrated that a potential diagnostic tool for detecting Covid-19 using sugars will work with a virus rather than just its proteins, a significant step in making it a viable test in future.

25 Sep 2020

About 10% patients with severe disease create auto-antibodies that attack the immune system

People infected by the novel coronavirus can have symptoms that range from mild to deadly. Now, two new analyses suggest that some life-threatening cases can be traced to weak spots in patients' immune systems.

25 Sep 2020

India and Denmark to benefit from NTNU COVID-19 tests

A highly sensitive COVID-19 test, developed by researchers from the Norwegian University of Science and Technology (NTNU), relies on magnetic nanoparticles to extract viral RNA.

24 Sep 2020

Researchers develop a cheaper, faster and accurate COVID-19 test

Researchers at Karolinska Institutet have developed a method for fast, cheap, yet accurate testing for COVID-19 infection. The method simplifies and frees the testing from expensive reaction steps, enabling upscaling of the diagnostics.

23 Sep 2020

Owlstone Medical releases positive study results on use of breath biopsy for better liver disease diagnosis

Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.

From Owlstone Medical Ltd 23 Sep 2020

NIH expands clinical trials to evaluate convalescent plasma as a treatment for COVID-19

Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19.

22 Sep 2020

UConn researchers validate clinical feasibility of CRISPR-based platform for COVID-19 testing

In March, researchers in the Department of Biomedical Engineering-- a shared department in the schools of Dental Medicine, Medicine, and Engineering--began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV virus, the novel coronavirus (SARS-CoV-2).

19 Sep 2020

EMPAIA project aims to build a platform for AI-assisted solutions

The EMPAIA project, which is led by Charité - Universitätsmedizin Berlin, has been crowned one of the winners of the AI Innovation Competition organized by the Federal Ministry for Economic Affairs and Energy (BMWi).

18 Sep 2020

Hannover and Rostock team up to develop non-invasive optical melanoma diagnostics

Leibniz University Hannover and Rostock University Medical Center receive funding for the development of non-invasive optical melanoma diagnostics.

17 Sep 2020

Researchers monitor changes in brain activity associated with learning new words

How much time does a brain need to learn a new word? A team of Skoltech researchers and their colleagues monitored changes in brain activity associated with learning new words and found that cortical representations of the sound and meaning of these words may form in just 1 to 2 hours after exposure without any night's sleep consolidation, as earlier research suggested.

17 Sep 2020

Diagnostics News and Research

Study shows how cancer cells gain access to nerve signal to enter the bloodstream

New commitments from governments and organizations support a unified approach to end pandemic

NIH awards $5 million grant to reduce COVID-19-related health disparities

Discovery of high affinity binders for SARS-CoV-2 spike protein

Abacus Diagnostica's new multiplex assay provides reliable influenza, COVID-19 diagnosis in 75 minutes

PrimeStore® MTM novel viral transport media successfully evaluated by Public Health England for SARS-CoV-2 inactivation

UCLA researchers receive $13 million NIH grant to combat melanoma

New agreements to ensure all countries have fair access to COVID-19 rapid diagnostic tests

Interdisciplinary team wins NIH grant to develop a device for early oral cancer detection

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

New diagnostic tool may allow on-the-spot detection of coronavirus infection

About 10% patients with severe disease create auto-antibodies that attack the immune system

India and Denmark to benefit from NTNU COVID-19 tests

Researchers develop a cheaper, faster and accurate COVID-19 test

Owlstone Medical releases positive study results on use of breath biopsy for better liver disease diagnosis

NIH expands clinical trials to evaluate convalescent plasma as a treatment for COVID-19

UConn researchers validate clinical feasibility of CRISPR-based platform for COVID-19 testing

EMPAIA project aims to build a platform for AI-assisted solutions

Hannover and Rostock team up to develop non-invasive optical melanoma diagnostics

Researchers monitor changes in brain activity associated with learning new words

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News